Blogs
ICH E6(R3) Good Clinical Practice: Modernizing Clinical Trials and Aligning with YPrime’s Innovations
The ICH E6(R3) guideline represents a significant evolution in clinical trial methodologies, emphasizing quality…
Evaluating eCOA Options for Oncology Clinical Trials
In oncology clinical trials, selecting the right eCOA platform is critical to ensuring trial success…
AI in Clinical Trials—The FDA’s New Draft Guidance
The FDA’s draft guidance recognizes AI’s potential to expedite medical product development, improve patient care, and…
Can Paper COA Deliver ALCOA?
With vulnerabilities like human error, ambiguous entries, and delayed documentation, paper COA falls short. Enter eCOA…
Connected Devices in Clinical Trials: Adoption Continues to Advance
The integration of connected devices in clinical trials enhances clinical research, elevating data collection, patient engagement, and overall study efficiency…
YPrime’s Commitment to the UN Global Compact
YPrime has joined the UN Global Compact, a milestone in our commitment to sustainable and responsible business practices…
YPrime 2025 “Year in Preview”
In this forward-looking analysis, 6 YPrime subject matter experts offer their unique insights into the priorities shaping the future of clinical trials…
Properly Scoping eCOA Projects—A Critical Success Factor in Clinical Trials
Successful eCOA implementation requires thorough protocol review and deep operational insight…
The Real Cost of Compromised Quality in Clinical Trials—and How to Prevent It
Quality is not merely a checkbox—it’s the bedrock of clinical trial success or failure…
We’ve got you covered with strategies and solutions to improve your clinical trial technology, reduce clinical research site burden, and transform your patient experience.
Let’s get started today!